NIH has released new solicitations related to the reauthorized SBIR program.
All Blog Posts
Proposed regulation would require senior agency approval before federal research awards are issued
A newly proposed federal regulation could affect how research grants are awarded to small businesses and other recipients.
From Breakthrough Technology to Startup Teams: How Founder Factory Is Building What’s Next in SE Wisconsin
In Southeast Wisconsin, Founder Factory is launching startups around validated technologies, not just ideas.
An overview of the ART program at DoW
The Accelerated Research for Transition (ART) program is a Department of War (DoW) initiative designed to help promising SBIR/STTR technologies transition from research into actual military use.
SBIR/STTR Alternative: Long Range Broad Agency Announcements (LRBAAs)
Several federal agencies are actively accepting submissions through Long Range Broad Agency Announcements (LRBAAs).
NIH Funding Priorities
While we’re all very aware of the challenges tied to the reauthorization process, I also want to keep an eye on topics that matter for the long term— especially for those putting together SBIR proposals in the future.
What to do with my NIH SBIR?
Rob Baranowski, MS, JD So, you have an NIH SBIR ready to go, but the SBIR program is still not reauthorized.
Unlock Translational Momentum with the Catalyze Grant
The NIH Catalyze program empowers innovators to fast-track heart, lung, blood, and sleep (HLBS) discoveries toward real-world impact.
Successful Business Transitioning Characteristics
I was recently asked “What distinguishes SBIR/STTR companies that successfully transition into investor-ready ventures? Are there certain characteristics?” Here are a couple of points that struck me right away.
Foreign Risk vs. SBA Red Tape Hotline
This summer we posted about the unfortunate circumstances some of our NIH applicants have had with failing to pass the foreign risk assessment.